I agree with Pete from the perspective that it is best to

New Post Public Reply Private Reply Replies (4) Message Board
Mo bandg #60960
492
I agree with Pete from the perspective that it is best to not get caught up with short term timing expectations but bandg brings up a very good point in that it would be risky and IMO foolish, to not maintain a full position while we wait for an IPIX partnership to get finalized. Leo has surprised us in the past with news like the European Subsidiary announcement that no one saw coming. A major partnership deal or other big event could be announced at any time at which point IPIX share price could rapidly rise. Another small and criminally manipulated OTC stock, PTOI had traded under 1 cent and sat at 2 cents with minimal volume for a very long time. Long term shareholders were not selling at ridiculously compressed shares prices. (Sound familiar?) In the past 2 weeks it appears that some large entity is acquiring a large position and has driven up PTOI SP from .02 to .095 which is a huge percentage increase but IMO is just the infancy of a very large run. This is an example that the criminals will keep SP artificially low UNTIL THEY CAN’T. This same scenario of new demand driving up SP could happen to IPIX at any point but NONE of us can predict the WHEN. The criminals desperately need Longs to sell them REAL SHARES. One of the criminal strategies and false narratives will be “No deal is coming anytime soon so you might as well implement some tax-loss selling before 12/31 as you will be able to buy back your shares at the same or lower price 31 days later”. The criminals will continue to compress IPIX SP and will do their best to push IPIX under the 12/31/18 price of 7 cents. In the short term maybe the criminals will be successful and maybe they won’t. Many Longs will take advantage of the SHORT TERM ridiculously low SP and add to their position and smart LONGS will not risk being on the sidelines when a deal could be announced that drives IPIX SP into the dollars. Long term IPIX investors with patience will be handsomely rewarded IMO.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading